The system has received pre-market approval from the U.S. Food and Drug Administration, and is the first neurostimulation system that can be upgraded without the need of a surgical replacement of the device.
Dr. Darnule is an anesthesiologist, fellowship-trained in chronic pain management.
More Articles on Spine:
Hospital for Special Surgery Names Dr. Todd Albert Surgeon-in-Chief
Costs for SI Joint Disruption, Sacroiliitis About $270M Over 5 Years
The Robotic Difference: How New Technology Could Impact Spine
